Leeds John S, Höroldt Barbara S, Sidhu Reena, Hopper Andrew D, Robinson Kerry, Toulson Bonnie, Dixon Lynn, Lobo Alan J, McAlindon Mark E, Hurlstone David P, Sanders David S
Gastroenterology and Liver Unit, Royal Hallamshire Hospital, Sheffield, UK.
Scand J Gastroenterol. 2007 Oct;42(10):1214-20. doi: 10.1080/00365520701365112.
The relationship between coeliac disease and inflammatory bowel disease (IBD) is controversial. The aim of this study was to determine the prevalence of coeliac disease in IBD and the prevalence of IBD in coeliac disease.
Patients were enrolled from specialist IBD and coeliac clinics. Antigliadins, endomysial, tissue transglutaminase antibody and total IgA levels were measured in IBD patients. Patients with positive antibodies were offered a duodenal biopsy. The notes on coeliac patients were reviewed for colonoscopic and biopsy findings. Controls were recruited from the local population.
The study included 305 patients with coeliac disease, 354 with IBD and 601 healthy controls. The IBD group comprised 154 ulcerative colitis (UC) cases, 173 Crohn's disease, 18 indeterminate colitis and 9 cases of microscopic colitis. Forty-seven patients had positive antibodies and 3 had villous atrophy on biopsy. All three patients had positive anti-tissue transglutaminase antibodies but only two were endomysial antibody (EMA) positive. Ten coeliac patients had IBD (5 UC and 5 lymphocytic colitis). Five controls had coeliac disease and 2 had IBD (1 Crohn's disease and 1 UC). Stepwise multiple logistic regression showed only antibody positivity as being significant (p<0.0001).
The prevalence of IBD in coeliac disease was increased 10-fold compared with that in controls (odds ratio 9.98, 95% CI 2.8-45.9, p=0.0006), while the prevalence of coeliac disease in IBD was comparable with that in controls (odds ratio 1.02, 95% CI, 0.24-4.29, p=1.0).
乳糜泻与炎症性肠病(IBD)之间的关系存在争议。本研究的目的是确定IBD中乳糜泻的患病率以及乳糜泻中IBD的患病率。
患者来自IBD专科诊所和乳糜泻诊所。检测IBD患者的抗麦醇溶蛋白、肌内膜、组织转谷氨酰胺酶抗体和总IgA水平。抗体阳性的患者接受十二指肠活检。回顾乳糜泻患者的病历以获取结肠镜检查和活检结果。对照组从当地人群中招募。
该研究纳入了305例乳糜泻患者、354例IBD患者和601例健康对照。IBD组包括154例溃疡性结肠炎(UC)病例、173例克罗恩病、18例未定型结肠炎和9例显微镜下结肠炎。47例患者抗体阳性,3例活检显示绒毛萎缩。所有3例患者抗组织转谷氨酰胺酶抗体均为阳性,但只有2例肌内膜抗体(EMA)阳性。10例乳糜泻患者患有IBD(5例UC和5例淋巴细胞性结肠炎)。5例对照患有乳糜泻,2例患有IBD(1例克罗恩病和1例UC)。逐步多元逻辑回归显示只有抗体阳性具有显著性(p<0.0001)。
与对照组相比,乳糜泻中IBD的患病率增加了10倍(优势比9.98,95%可信区间2.8 - 4 . 59,p = 0.0006),而IBD中乳糜泻的患病率与对照组相当(优势比1.02,95%可信区间0.24 - 4.29,p = 1.0)。